Pasar al contenido principal

MARCO METODOLOGICO PARA LA MONITORIZACION ONLINE DE LA DOSIS-RESPUESTA EN LA APERTURA DE LA BARRERA HEMATOENCEFALICA MEDIANTE ULTRASONIDO FOCAL

PID2021-127800OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION DE INVESTIGACION HM HOSPITALES

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

BBB opening with focused ultrasound in nonhuman primates and Parkinson's disease patients: Targeted AAV vector delivery and PET imaging

  • Blesa, Javier
  • Pineda-Pardo, José A
  • Inoue, Ken-Ichi
  • Gasca-Salas, Carmen
  • Balzano, Tiziano
  • Del Rey, Natalia López-González
  • Reinares-Sebastián, Alejandro
  • Esteban-García, Noelia
  • Rodríguez-Rojas, Rafael
  • Márquez, Raquel
  • Ciorraga, María
  • Del Álamo, Marta
  • García-Cañamaque, Lina
  • Ruiz de Aguiar, Santiago
  • Rachmilevitch, Itay
  • Trigo-Damas, Inés
  • Takada, Masahiko
  • Obeso, José A
Intracerebral vector delivery in nonhuman primates has been a major challenge. We report successful blood-brain barrier opening and focal delivery of adeno-associated virus serotype 9 vectors into brain regions involved in Parkinson's disease using low-intensity focus ultrasound in adult macaque monkeys. Openings were well tolerated with generally no associated abnormal magnetic resonance imaging signals. Neuronal green fluorescent protein expression was observed specifically in regions with confirmed blood-brain barrier opening. Similar blood-brain barrier openings were safely demonstrated in three patients with Parkinson's disease. In these patients and in one monkey, blood-brain barrier opening was followed by 18F-Choline uptake in the putamen and midbrain regions based on positron emission tomography. This indicates focal and cellular binding of molecules that otherwise would not enter the brain parenchyma. The less-invasive nature of this methodology could facilitate focal viral vector delivery for gene therapy and might allow early and repeated interventions to treat neurodegenerative disorders., We are grateful to V. Soler (Medical Director), L. Díaz-Jiménez Fernandez, M. Lorca-Moreno, and S. Casas from the Radiology Department and U. Alcañas Martínez and Y. Gomez Gonzalez of the Nuclear Medicine Department in HM Puerta del Sur Hospital. Wethank J. H. Kordower and J. F. Aubry for helpful discussions and insightful comments on themanuscript. We thank L. Phillips, MD for English language editing of this manuscript. Funding: This work was supported by Ministerio de Ciencia e Innovación y Universidades (PID2019-111045RB-I00) (J.A.O.), (PID2021-127800OA-I00) (J.A.P.-P.), and (IJC2020 -043918-I) (T.B.);Instituto de Salud Carlos III Miguel Servet (MS19/00200) and FIS (PI20/00496) (J.B.) and PFIS (FI21/000919) (N.E.-G.); Fundación Tatiana Pérez de Guzmán el Bueno (J.B.); Grant-in-Aid forScientific Research from Japan Society for the Promotion of Science (no. 19H05467 to M.T. and22H05157 and 22 K19480 to K.I.); Japan Agency for Medical Research and Development (J P19dm0207077 to M.T.); Focused Ultrasound Foundation; Fundación MAPFRE; FundaciónBBVA; and a joint project between Fundación de Investigación HM Hospitales and Insightec Ltd.Author contributions: Conceptualization: J.B., J.A.P.-P., C.G.-S., and J.A.O. Methodology: J.B.,J.A.P.-P., K.I., C.G.-S., T.B., N.L.-G.R., A.R.-S., N.E.-G., R.R.-R., R.M., M.C., M.A., L.G.-C., S.R.A., I.T.-D., I.R.,and M.T. Funding acquisition: J.B., J.A.P.-P., K.I., M.T., and J.A.O. Writing—original draft: J.B., J.A.P.-P., K.I., T.B., M.T., and J.A.O. Writing—review and editing: All authors read and approved the finalversion. Competing interests: I.R. is an employee of Insightec Ltd. that developed andcommercializes the focused ultrasound transducer used in this study. J.A.O. has been a memberof the Advisory Board of Insightec Ltd. (2021–2022). The authors declare that they have noother competing interests. Data and materials availability: All data needed to evaluate theconclusions in the paper are present in the paper and/or the Supplementary Materials., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The road ahead to successful BBB opening and drug-delivery with focused ultrasound

  • López-Aguirre, Miguel
  • Castillo-Ortiz, Marta
  • Viña-González, Ariel
  • Blesa, Javier
  • Pineda-Pardo, José A.
This review delves into the innovative technology of Blood-Brain Barrier (BBB) opening with low-intensity focused ultrasound in combination with microbubbles (LIFU-MB), a promising therapeutic modality aimed at enhancing drug delivery to the central nervous system (CNS). The BBB's selective permeability, while crucial for neuroprotection, significantly hampers the efficacy of pharmacological treatments for CNS disorders. LIFU-MB emerges as a non-invasive and localized method to transiently increase BBB permeability, facilitating the delivery of therapeutic molecules. Here, we review the procedural stages of LIFU-MB interventions, including planning and preparation, sonication, evaluation, and delivery, highlighting the technological diversity and methodological challenges encountered in current clinical applications. With an emphasis on safety and efficacy, we discuss the crucial aspects of ultrasound delivery, microbubble administration, acoustic feedback monitoring and assessment of BBB permeability. Finally, we explore the critical choices for effective BBB opening with LIFU-MB, focusing on selecting therapeutic agents, optimizing delivery methods, and timing for delivery. Overcoming existing barriers to integrate this technology into clinical practice could potentially revolutionize CNS drug delivery and treatment paradigms in the near future., This review was supported by the Fundación de Investigación HM Hospitales (Madrid); Ministerio de Ciencia e Innovación y Universidades, Spanish Government (Grant number PID2021-127800OA-I00); Instituto de Salud Carlos III Miguel Servet (MS19/00200) and FIS (PI23/00672)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Temporal dynamics of neurovascular unit changes following blood-brain barrier opening in the putamen of non-human primates

  • Balzano, Tiziano
  • Pineda-Pardo, José A
  • Esteban-García, Noelia
  • López-Aguirre, Miguel
  • Reinares-Sebastián, Alejandro
  • Trigo-Damas, Inés
  • Takada, Masahiko
  • Obeso, José A
  • Blesa, Javier
Low-intensity focused ultrasound (LIFU) combined with intravenously circulating microbubbles has recently emerged as a novel approach for increasing delivery through the blood-brain barrier (BBB). This technique safely and transiently enables therapeutic agents to overcome the BBB, which typically poses a significant obstacle for treatment of brain disorders. However, the full impact of LIFU on the entire neurovascular unit (NVU), as well as the mechanisms and factors involved in restoring BBB integrity still require further elucidation. We conducted immunohistochemical analyses of the putamen in non-human primates to monitor changes over time [immediately post-treatment (3 h) and at 7- and 30-days post-BBB opening] in vascular, glial, and immune cells. Additionally, we examined the dynamic interactions among these elements and their role in the restorative process at the BBB level. A mild inflammatory response primarily involving microglia, astrocytes, and T- and B-lymphocytes was observed in the treated putamen acutely after BBB opening. These cells, recruited in response to the vascular changes, stimulate upregulation of PDGFRβ, a pericyte-specific marker, and VEGF-A, a pro-angiogenic factor. This was associated with vascular sprouting by 7 days post-BBB opening. Importantly, no notable long-term alterations were observed in the NVU 30 days post-BBB opening. These results offer further evidence regarding the efficacy and safety of LIFU in achieving BBB opening in the primate brain, indicating that nearly all changes in the NVU revert to baseline within 30 days post-treatment. This also suggests that angiogenesis may play an important role in restoring vascular integrity after BBB opening., The expert technical assistance with histology of Maria Ciorraga, Noelia Mercado García and Raquel Márquez Lopez is gratefully acknowledged. Support ensuring the highest standards of animal welfare was provided by Cristina Gil, Jennifer Ribeiro, Juan Santos, and Eduardo Alvarez. We thank Lawrence Phillips, MD for English language editing of this manuscript. T.B. is currently funded by Ayudas para contratos Juan de la Cierva Incorporacion (IJC2020-043918-I) of the Ministry of Science and Innovation, the National Research Agency and the European Union NextGenerationEU/PRTR (Recovery, Transformation and Resilience Plan); J.A.P.P. by Ministerio de Ciencia e Innovación y Universidades, Spanish Government (Grant number PID2021-127800OA-I00); N.E.G. by Instituto de Salud Carlos III PFIS (FI21/000919); J.A.O. by Ministerio de Ciencia e Innovación y Universidades (PID2019-111045RB-I00); and J.B. by Instituto de Salud Carlos III Miguel Servet Program (CP19/00200), FIS (PI23/00672) and Fundación Tatiana Pérez de Guzmán el Bueno. Focused Ultrasound Foundation; Fundación MAPFRE; Fundación BBVA; and a joint project between Fundación de Investigación HM Hospitales and Insightec Ltd., Peer reviewed